Abstract: The invention relates to the field of health food technologies, and particularly to a composition and an application thereof in preparing a product for protecting mitochondria. The invention provides a composition, the raw materials of which include Haematococcus pluvialis, Lycium ruthenicum, Cordyceps militaris and nicotinamide. The composition has the effects of improving an oxidative stress level under a mitochondrial dysfunction and delaying mitochondrion-related aging. Compared with a single constituent, constituents in the composition cooperate with each other to produce a synergistic effect, which significantly improves an effect of protecting a mitochondrial function.

Abstract: The invention relates to the field of health food technologies, and particularly to a composition and an application thereof in preparing a product for protecting mitochondria. The invention provides a composition, the raw materials of which include Haematococcus pluvialis, Lycium ruthenicum, Cordyceps militaris and nicotinamide. The composition has the effects of improving an oxidative stress level under a mitochondrial dysfunction and delaying mitochondrion-related aging. Compared with a single constituent, constituents in the composition cooperate with each other to produce a synergistic effect, which significantly improves an effect of protecting a mitochondrial function.

Abstract: The invention discloses a polypeptide with a function of inhibiting A?42 protein aggregation and use thereof, and a gene encoding the polypeptide. The polypeptide with the function of inhibiting A?42 protein aggregation is called PW-5, and has an amino acid sequence of Pro-Pro-Lys-Asn-Trp. The polypeptide with the function of inhibiting A?42 protein aggregation according to the present invention can effectively inhibit aggregation and deposition of A?42 protein, so as to effectively improve memory ability of a body; and can be applied to preparation of a drug or a food with inhibiting A?42 protein aggregation function or can be applied to preparation of a drug, a health product or a food for preventing or treating Alzheimer's disease, so that preventing and treating situations of the Alzheimer's disease can be effectively improve.

Abstract: An embedded touch control display device is disclosed. The embedded touch control display device includes a first substrate and a second substrate which are set oppositely; an in-plane switching (IPS) or fringe field switching (FFS) display mode display structure and a capacitance touch structure which are set between the first substrate and the second substrate, and the IPS or FFS display mode display structure is located on the first substrate and comprises a pixel electrode layer, a first medium layer, a public electrode layer and a crystal layer, and the capacitance touch structure is located on the second substrate and comprises touch electrode and a second medium layer; an planarization layer which is located between the second medium layer and the crystal layer; the distance between the touch electrode and the crystal layer is 4 micrometers to 7 micrometers.

Abstract: An embedded touch control display device is disclosed. The embedded touch control display device includes a first substrate and a second substrate which are set oppositely; an in-plane switching (IPS) or fringe field switching (FFS) display mode display structure and a capacitance touch structure which are set between the first substrate and the second substrate, and the IPS or FFS display mode display structure is located on the first substrate and comprises a pixel electrode layer, a first medium layer, a public electrode layer and a crystal layer, and the capacitance touch structure is located on the second substrate and comprises touch electrode and a second medium layer; an planarization layer which is located between the second medium layer and the crystal layer; the distance between the touch electrode and the crystal layer is 4 micrometers to 7 micrometers.